BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18710984)

  • 1. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
    Okuda S; Oshio K; Shinmoto H; Tanimoto A; Asada H; Fujii T; Yoshimura Y; Kuribayashi S
    Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
    Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
    Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists.
    Nagai K; Asano R; Sekiguchi F; Asai-Sato M; Miyagi Y; Miyagi E
    Am J Obstet Gynecol; 2023 Feb; 228(2):207.e1-207.e9. PubMed ID: 36150519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
    Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
    Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the vascular bed volume of uterine fibroids after hormonal treatment: evaluation with dynamic double-echo R₂* imaging.
    Okuda S; Oshio K; Asada H; Tanimoto A; Jinzaki M; Furuya M; Yoshimura Y; Kuribayashi S
    Magn Reson Med Sci; 2012; 11(4):283-9. PubMed ID: 23269015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
    Matsuno Y; Yamashita Y; Takahashi M; Katabuchi H; Okamura H; Kitano Y; Shimamura T
    Acta Radiol; 1999 Nov; 40(6):656-62. PubMed ID: 10598858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
    Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
    Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.
    Zawin M; McCarthy S; Scoutt L; Lange R; Lavy G; Vulte J; Comite F
    Radiology; 1990 May; 175(2):503-6. PubMed ID: 2109336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization.
    Lee MS; Kim MD; Jung DC; Lee M; Won JY; Park SI; Lee DY; Lee KH
    J Vasc Interv Radiol; 2013 Sep; 24(9):1361-5. PubMed ID: 23891046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome.
    deSouza NM; Williams AD
    Radiology; 2002 Feb; 222(2):367-74. PubMed ID: 11818601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
    Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
    Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate.
    Palmara V; Triolo O; Benedetto V; Lo Re C; Sturlese E; Retto G; Santoro G
    Gynecol Obstet Invest; 2010; 69(2):131-5. PubMed ID: 19996602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.